21st Century Manufacturing of Injectable Pharmaceuticals

|

article image
This pharmaceutical manufacturing infographic explores the factors changing the development and production of sterile injectables. Learn more about the factors driving the need for agility in manufacturing, and new innovations that provide superior flexibility and aseptic assurance.

Spotlight

CELOGEN PHARMA PVT LTD

We would like to introduce ourselves as a new leading pharmaceutical formulations exporter/manufacturer based in India. Currently operating in some 15 countries globally we cover parts of West Africa, East Africa, South Asia, South East Asia, the Middle East & Europe. Apart from promoting our branded products in the retail sector, we also participate in a number of global tenders which are backed by the Unicef, World Bank, WHO & the local governments in a number of countries. The team comprises of a group of first generation marketing expats, who are backed up by some of the best technocrats in the field today. We have four Manufacturing Bases in Southern parts of India, manufacturing a variety of products. Our specialty however lies in the fabrication of 1st,2nd,3rd & 4th Generation Anti-biotics, ONCOLOGY Injectables, nutritional products such as Multi-Vitamins & essential oils in soft gel forms, anti-malarial & anti-TB drugs. We have also recently launched a number of higher end ant

OTHER ARTICLES

Top Specialty Pharmacy Therapy Areas

Article | March 16, 2020

Accelerated by advancements in cancer treatments and a growing emphasis on personalized and precision medicine, specialty pharmacy represents a rapidly growing sector within the healthcare industry. In fact, the market is projected to grow to $500 billion by the end of this year—up from $200 billion in total U.S. specialty drug spending in 2017. Industry growth of this magnitude creates challenges for those looking to understand and penetrate the market. It can be difficult, after all, to maintain updated information about high-priority drug therapy areas or facility affiliations in a market that’s constantly changing.

Read More

Comparing HydroxyChloroquine Trials

Article | March 16, 2020

One minor side effect of the pandemic is that perhaps more people will learn about what drug research and clinical trials can really be like. Today’s example: we have a clinical trial of hydroxychloroquine from Wuhan that has just published on a preprint server. What’s good is that this one is blinded, randomized, and controlled (like the earlier hydroxychloroquine which one I blogged about here from Zhejiang University, so we can actually talk about it rather than just spend all our time wondering what the heck is going on.

Read More
PHARMACY MARKET

A pharma outsourcing mission

Article | March 16, 2020

In a way, getting through the initial stages of a complex pharmaceutical project that is being outsourced to a contract development and manufacturing organization is like getting a rocket off the ground. Many drug developers express frustration with the time it often takes during the initial stages of working with a CDMO — from the time they first reach out to a CDMO for help until they receive a proposal. Some have described it as months of silence from when they send a request for proposal (RFP) until they have a proposal in hand. The initial stages of a relationship between drug sponsor and CDMO often do not get the attention it deserves, and valuable time is lost, delaying projects and delaying delivery of therapeutics to patients. The quick scheduling of the ACT meeting with the right attendees can deliver immediate answers to key questions needed by the drug sponsor for effective planning and can help propel projects to a successful launch.

Read More

Top Pharmaceutical Firms Urge FDA to Adopt Blockchain for Drug Tracking

Article | March 16, 2020

Leading market participants in the United States pharmaceutical industry, logistics firms, distributors and other stakeholders in the pharma supply chain have come together to publish a report buttressing the need for industry players to adopt blockchain for tracking prescription drugs, following the successful completion of a DLT pilot project with the Food and Drug Administration (FDA), according to reports on February 24, 2020. Though nascent, blockchain technology, the building blocks of Bitcoin (BTC) and other cryptocurrencies are fast gaining ground across various ecosystems, due to its immutability, security, privacy, and other intricate properties. In the latest development, 25 leading manufacturers of pharmaceutical products, logistics partners and other market participants in the pharma supply chain, have published a report that highlights the importance of blockchain technology in drug traceability.

Read More

Spotlight

CELOGEN PHARMA PVT LTD

We would like to introduce ourselves as a new leading pharmaceutical formulations exporter/manufacturer based in India. Currently operating in some 15 countries globally we cover parts of West Africa, East Africa, South Asia, South East Asia, the Middle East & Europe. Apart from promoting our branded products in the retail sector, we also participate in a number of global tenders which are backed by the Unicef, World Bank, WHO & the local governments in a number of countries. The team comprises of a group of first generation marketing expats, who are backed up by some of the best technocrats in the field today. We have four Manufacturing Bases in Southern parts of India, manufacturing a variety of products. Our specialty however lies in the fabrication of 1st,2nd,3rd & 4th Generation Anti-biotics, ONCOLOGY Injectables, nutritional products such as Multi-Vitamins & essential oils in soft gel forms, anti-malarial & anti-TB drugs. We have also recently launched a number of higher end ant

Events